Clinical Trial

Exercise Intensity

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Patients receiving regular hemodialysis (HD) treatments are at a higher risk of cardiovascular events and death as HD can cause a decrease in the pumping of the heart during treatment called 'stunning'. Intradialytic exercise has emerged as a safe and effective non-drug approach to improve cardiovascular health and is now recommended for patients undergoing HD. It is currently advised that HD patients engage in at least 30 minutes of moderate to vigorous exercise three times per week. This study will evaluate the impact of exercise intensity in the HD population and determine if high impact exercise can offer better protection to the heart against HD-induced myocardial stunning.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-05; most recent amendment 2026-04-28.
Status change: Recruiting → Active, Not Recruiting 2026-04-28
Status change: Not Yet Recruiting → Recruiting 2025-09-23
Trial Details
NCT Number NCT07119593
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions Dialysis, Cardioprotection
Enrollment 15 participants
Start Date 2025-09-22
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29